Ursodesoxycholic acid is an FFA4 agonist and reduces hepatic steatosis via FFA4 signaling
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference43 articles.
1. Discovery of chromane propionic acid analogues as selective agonists of GPR120 with in vivo activity in rodents;Adams;ACS Med. Chem. Lett.,2017
2. Non-acidic free fatty acid receptor 4 agonists with antidiabetic activity;Azevedo;J. Med. Chem.,2016
3. Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH;Carino;Biochim. Biophys. Acta Mol. Cell Biol. Lipids,2019
4. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease;Castro;J. Hepatol.,2013
5. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease;Chavez-Tapia;BMC Gastroenterol.,2012
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives;Frontiers in Pharmacology;2024-03-21
2. Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development;Pharmacological Research;2023-10
3. The emerging significance of mitochondrial targeted strategies in NAFLD treatment;Life Sciences;2023-09
4. UDCA and INT-777 suppress cardiac fibrosis triggered by IL-11 through involvement of TGR5;2022-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3